FTO and breast cancer: In contrast, carriers of the AG genotype rs9930506 showed a lower risk for BC even after adjusted analysis; the AG genotype of FTO rs9930506 was more frequent in the control group compared with BC patients (P = 0.0025), supporting a protector role.